INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Conformational Changes of Blood ACE in Chronic Uremia

Show full item record

Bookmark or cite this item:

Files in this item

File Description Format
PDF journal.pone.0049290.pdf (1MB) Main Article PDF
Title: Conformational Changes of Blood ACE in Chronic Uremia
Author(s): Petrov, Maxim N.; Shilo, Valery Y.; Tarasov, Alexandr V.; Schwartz, David E.; Garcia, Joe G. N.; Kost, Olga A.; Danilov, Sergei M.
Abstract: Background: The pattern of binding of monoclonal antibodies (mAbs) to 16 epitopes on human angiotensin I-converting enzyme (ACE) comprise a conformational ACE fingerprint and is a sensitive marker of subtle protein conformational changes. Hypothesis: Toxic substances in the blood of patients with uremia due to End Stage Renal Disease (ESRD) can induce local conformational changes in the ACE protein globule and alter the efficacy of ACE inhibitors. Methodology/Principal Findings: The recognition of ACE by 16 mAbs to the epitopes on the N and C domains of ACE was estimated using an immune-capture enzymatic plate precipitation assay. The precipitation pattern of blood ACE by a set of mAbs was substantially influenced by the presence of ACE inhibitors with the most dramatic local conformational change noted in the N-domain region recognized by mAb 1G12. The "short" ACE inhibitor enalaprilat (tripeptide analog) and "long" inhibitor teprotide (nonapeptide) produced strikingly different mAb 1G12 binding with enalaprilat strongly increasing mAb 1G12 binding and teprotide decreasing binding. Reduction in S-S bonds via glutathione and dithiothreitol treatment increased 1G12 binding to blood ACE in a manner comparable to enalaprilat. Some patients with uremia due to ESRD exhibited significantly increased mAb 1G12 binding to blood ACE and increased ACE activity towards angiotensin I accompanied by reduced ACE inhibition by inhibitory mAbs and ACE inhibitors. Conclusions/Significance: The estimation of relative mAb 1G12 binding to blood ACE detects a subpopulation of ESRD patients with conformationally changed ACE, which activity is less suppressible by ACE inhibitors. This parameter may potentially serve as a biomarker for those patients who may need higher concentrations of ACE inhibitors upon antihypertensive therapy.
Issue Date: 2012-11
Publisher: Public Library of Science
Citation Info: Petrov, M. N. Shilo, V. Y. Tarasov, A. V. Schwartz, D. E. Garcia, J. G. N. Kost, O. A. Danilov, S. M. Conformational Changes of Blood ACE in Chronic Uremia. Plos One. Nov 2012;7(11). DOI: 10.1371/journal.pone.0049290
Type: Article
Description: The original version is available through Public Library of Science at DOI: 10.1371/journal.pone.0049290. © 2012 Petrov et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
ISSN: 1932-6203
Sponsor: This work was partly financially supported by the Russian Fund for Basic Research (grant number 11-04-01923-a).
Date Available in INDIGO: 2013-11-22

This item appears in the following Collection(s)

Show full item record


Country Code Views
United States of America 278
China 142
Germany 24
Russian Federation 20
Ukraine 15


My Account


Access Key